Trials / Not Yet Recruiting
Not Yet RecruitingNCT06882187
ALI in Cancer Patients
Outcomes of Acute Limb Ischemia in Cancer Patients .
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to describe and evaluate the outcomes of cancer patients presenting with and treated for ALI at our center .
Detailed description
Acute limb ischemia (ALI) is a vascular emergency and is associated with significant morbidity and mortality. Peripheral arterial embolism or thrombosis from malignant disease is uncommon and a rare cause of acute limb ischemia. Limb ischemia can be caused by emboli from the tumor itself, from metastatic deposits within large vessels, as well as the tumors of adjacent organs such as the lung, which invade the left or right atrium of the heart and then disseminate to the main arteries of the body. This acute event may be the first indication of malignant disease in the patient.
Conditions
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2026-05-01
- Completion
- 2026-07-01
- First posted
- 2025-03-18
- Last updated
- 2025-03-18
Source: ClinicalTrials.gov record NCT06882187. Inclusion in this directory is not an endorsement.